Inflammation & Allergy - Drug Targets: Indexing (Scopus), Scope & Papers

Publishing your own paper?

Get it ready for the right journal with a PhD expert in your field.

Manuscript Auditing

A PhD reviewer in your exact area sends a structured, section-by-section critical review.

AI plagiarism and similarity report included
Secure, confidential upload

Audit duration: within 1 weekCheck price →

If the journal needs LaTeX

LaTeX Template Conversion

We convert your manuscript into the LaTeX template your target journal requires.

Check price →

If your paper was out of scope

Journal Selection & Submission

Up to 5 journals matched to your indexing (SCIE / Scopus) and quartile
Submission handled, with weekly updates

With LaTeX conversion: within 2 Working DaysCheck price →

What is ScholarsColab?

ScholarsColab is a freelancing platform built for researchers, with a pool of research doctorates registered to mentor them. Hire one in your research area and cut your research timeline from 2 years to 2 months.

Know more →

At a glanceInflammation & Allergy - Drug Targets is listed in Scopus. Published by Bentham Science Publishers, it has 439 published works, cited 15,283 times (h-index 62). Papers by ScholarsColab mentors and the researchers we track appear here as soon as they publish in it. Data updated 22 October 2026.

IndexingScopusConfirm on the official lists before you submit

RetractionsNoneNone on record under this name

01Impact factor

Impact factor of Inflammation & Allergy - Drug Targets (2026)

Impact factor (2-year)0.00calculated by ScholarsColab

h-index62

Papers published439cited 15,283 times

The impact factor shown here is the 2-year mean citedness: citations received in a year by the papers Inflammation & Allergy - Drug Targets published in the two previous years, divided by the number of those papers. That is the same formula as the Journal Impact Factor, calculated by ScholarsColab. The journal is not listed in JCR 2024, so it has no official Journal Impact Factor from Clarivate; the value above is how often its recent papers are cited.

Quartile of Inflammation & Allergy - Drug Targets

A journal's quartile (Q1 to Q4) is its position within a subject category: Q1 is the top quarter. The official quartiles are published by Clarivate in Journal Citation Reports (by Journal Impact Factor, in Web of Science categories) and by Scimago as the SJR quartile (in Scopus categories). Inflammation & Allergy - Drug Targets is not listed in JCR 2024, so it has no JCR quartile. It is indexed in Scopus, so Scimago shows its SJR quartile. ScholarsColab does not show a quartile until it can show the official one; the impact factor and rank above are calculated from open data.

Citations and papers per year

Citations per year

Papers per year

Please check the final impact factor. The impact factor and APC on this page are calculated by ScholarsColab (updated 17 October 2026) and can differ from the official values. Confirm the current impact factor and charges on the journal’s website before you submit.

Is your paper a fit for Inflammation & Allergy - Drug Targets?

Most desk rejections come from a scope mismatch. Compare your title and abstract with what this journal really publishes. Free, no sign-up, about 2 minutes.

Check my paper for this journal Or find journals that fit my paper

02Fee waivers

APC waivers and discounts for Inflammation & Allergy - Drug Targets

Inflammation & Allergy - Drug Targets follows the waiver policy of its publisher, Bentham Science: 50% discount for corresponding authors in countries on Bentham's low-income list. Only the corresponding author's affiliation counts. Co-authors from other countries do not change the waiver.

Waivers apply to fully open access journals. If Inflammation & Allergy - Drug Targets is a hybrid journal, you can publish without any fee through the subscription route.

Your APC at Inflammation & Allergy - Drug TargetsPublishing from

Checking the waiver rules for your country…

03Indexing

Indexing of Inflammation & Allergy - Drug Targets

List	Status
Science Citation Index Expanded (SCIE)	Not listed
Social Sciences Citation Index (SSCI)	Not listed
Arts & Humanities Citation Index (AHCI)	Not listed
Emerging Sources Citation Index (ESCI)	Not listed
Scopus	✓ Listed
Journal Citation Reports 2024	Not listed

ISSN: 1871-5281
eISSN: 2212-4055
Publisher: Bentham Science Publishers all its journals →

From the indexing lists used on ScholarsColab, updated 1 March 2026. Indexing can change: confirm on the Web of Science Master Journal List or the Scopus source list before submitting. Official Journal Impact Factors and JCR quartiles are published by Clarivate; the impact factor on this page is calculated by ScholarsColab (see how the impact factor works).

Verify the indexing yourself

Each link opens the official record for this journal, searched by its ISSN where we have one.

04How to submit

How to submit to Inflammation & Allergy - Drug Targets

Read the guide for authors. It sets the article types, word limit, reference style and file format that Inflammation & Allergy - Drug Targets accepts. You find it on the journal's website at Bentham Science Publishers, usually under "For authors".
Format to the journal's style. Check whether it wants a Word file, a LaTeX file or a PDF for the first submission, and follow its reference style; many journals accept any clear format at first and ask for their style only after acceptance.
Check the fit. Read the aims and scope and a few recent issues; papers outside the scope are the most common reason for a desk rejection. The Journal Finder shows journals that published the closest work.
Check the fee. Inflammation & Allergy - Drug Targets is not a fully open access journal, so authors usually pay nothing unless they choose open access for their article or the journal charges page or colour fees. The guide for authors states the current charges.
Check your manuscript before you submit. The free Submission Readiness Check asks the seven questions our reviewers ask in every audit and takes about 2 minutes.

05Reviewer comments

Reviewer comments and rejection reasons for Inflammation & Allergy - Drug Targets

No reviewer or editor comments have been shared for this journal yet. Did you submit here? Help other researchers by sharing the comments you received, anonymously.

Planning to submit to Inflammation & Allergy - Drug Targets? A Manuscript Audit by a PhD reviewer in your area checks your paper for the issues reviewers raise most often.

Audit my paper before I submit →Not sure yet? Check if your paper is ready for this journal: free, no AI, under 5 seconds

FreeNo AI

Is Inflammation & Allergy - Drug Targets right for your paper? Find the right journal

Paste your title, keywords or abstract. See the journals that published the closest papers, with indexing, impact factor, review time and APC.

Try:

Publishing open access? Your author team may not have to pay the APC. Free APC waiver check for your country→

How it works

No AI or language model is used. Your words are matched against the titles of 157,109 real published journal papers, by our mentors and by other researchers (shown without names); journals are ranked by how many closely matching papers they published. Indexing comes from the SCIE, SSCI, AHCI, ESCI, Scopus and JCR 2024 lists, matched by journal name; the impact factor is calculated by ScholarsColab, not the official Clarivate value, and no quartile is shown until the official JCR or SJR quartile can be; review time is the median days from submission to acceptance (not every publisher publishes these dates). Always check a journal’s scope and current indexing before submitting.

Want a PhD expert to shortlist and handle the submission? Journal Selection & Submission matches your manuscript to up to 5 suitable journals by indexing and quartile. Check price →

06Questions

Frequently asked questions

What is the impact factor of Inflammation & Allergy - Drug Targets?

Based on ScholarsColab citation data (October 2026), the 2-year impact factor of Inflammation & Allergy - Drug Targets is 0.00: papers it published in the two previous years were cited 0.00 times on average in a year. The journal is not listed in JCR 2024, so it has no official Clarivate Journal Impact Factor.

What is the h-index of Inflammation & Allergy - Drug Targets?

The h-index of Inflammation & Allergy - Drug Targets is 62 (October 2026): 62 of its papers have each been cited at least 62 times. Its i10-index is 301.

What is the quartile of Inflammation & Allergy - Drug Targets?

Is Inflammation & Allergy - Drug Targets indexed in Scopus?

Yes. Inflammation & Allergy - Drug Targets appears in the Scopus list, according to the indexing lists used on ScholarsColab (updated 1 March 2026). Always confirm the current status on the official list before submitting.

Is Inflammation & Allergy - Drug Targets an SCIE journal?

Inflammation & Allergy - Drug Targets is not listed in SCIE or the other Web of Science indexes, according to the indexing lists used on ScholarsColab (updated 1 March 2026). Always confirm the current status on the official list before submitting.

Is Inflammation & Allergy - Drug Targets in Journal Citation Reports (JCR)?

Inflammation & Allergy - Drug Targets is not listed in the JCR 2024 list, according to the indexing lists used on ScholarsColab (updated 1 March 2026). Always confirm the current status on the official list before submitting.

Does Inflammation & Allergy - Drug Targets offer an APC waiver?

Inflammation & Allergy - Drug Targets follows the policy of Bentham Science: 50% discount for corresponding authors in countries on Bentham's low-income list. Only the corresponding author's affiliation counts. Co-authors from other countries do not change the waiver. Rules verified 27 October 2026; confirm on the publisher's page.